These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7508478)

  • 1. Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA.
    White ML; Ma JK; Birr CA; Trown PW; Carroll SF
    J Immunol Methods; 1994 Jan; 167(1-2):227-35. PubMed ID: 7508478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA.
    Schultz H; Csernok E; Johnston TW; Lockwood CM; Gross WL
    J Immunol Methods; 1997 Jul; 205(2):127-33. PubMed ID: 9294593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein.
    Horwitz AH; Williams RE; Nowakowski G
    Infect Immun; 1995 Feb; 63(2):522-7. PubMed ID: 7822017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative concentrations of endotoxin-binding proteins in body fluids during infection.
    Opal SM; Palardy JE; Marra MN; Fisher CJ; McKelligon BM; Scott RW
    Lancet; 1994 Aug; 344(8920):429-31. PubMed ID: 7520106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain.
    Dunn AC; Walmsley RS; Dedrick RL; Wakefield AJ; Lockwood CM
    J Infect; 1999 Jul; 39(1):81-7. PubMed ID: 10468134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
    Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.
    Pereira BJ; Sundaram S; Snodgrass B; Hogan P; King AJ
    J Am Soc Nephrol; 1996 Mar; 7(3):479-87. PubMed ID: 8704115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
    Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of bactericidal/permeability-increasing protein in disease: detection by ELISA.
    Dentener MA; Francot GJ; Smit FT; Froon AH; Pennings HJ; Wouters EF; Buurman WA
    J Infect Dis; 1995 Mar; 171(3):739-43. PubMed ID: 7876632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S
    Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein.
    Dentener MA; Smit FT; Francot GJ; Buurman WA
    J Infect Dis; 1994 Dec; 170(6):1483-9. PubMed ID: 7995988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes.
    Sundaram S; King AJ; Pereira BJ
    J Am Soc Nephrol; 1997 Mar; 8(3):463-70. PubMed ID: 9071715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
    Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
    J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
    Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW
    J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis.
    Zhao MH; Jones SJ; Lockwood CM
    Clin Exp Immunol; 1995 Jan; 99(1):49-56. PubMed ID: 7813109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and expression analysis on bactericidal permeability-increasing protein/lipopolysaccharide-binding protein of blunt snout bream, Megalobrama amblycephala.
    Tang L; Liang Y; Jiang Y; Liu S; Zhang F; He X; Wang T; Zhou Y; Zhong H; Yan J
    Fish Shellfish Immunol; 2015 Aug; 45(2):630-40. PubMed ID: 25982396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.